BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9765694)

  • 1. [Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy].
    Pötter R; Knocke TH
    Strahlenther Onkol; 1998 Sep; 174(9):488-9. PubMed ID: 9765694
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of vaginal recurrences in endometrial carcinoma by high-dose-rate brachytherapy.
    Sorbe B; Söderström K
    Anticancer Res; 2013 Jan; 33(1):241-7. PubMed ID: 23267151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature.
    Kamrava M; Beriwal S; Erickson B; Gaffney D; Jhingran A; Klopp A; Park SJ; Viswanathan A; Yashar C; Lin L
    Brachytherapy; 2017; 16(6):1129-1143. PubMed ID: 28888417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy.
    Pai HH; Souhami L; Clark BG; Roman T
    Gynecol Oncol; 1997 Aug; 66(2):300-7. PubMed ID: 9264580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy.
    Chapman CH; Maghsoudi K; Littell RD; Chen LM; Hsu IC
    Brachytherapy; 2017; 16(6):1152-1158. PubMed ID: 28802913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence.
    Petignat P; Jolicoeur M; Alobaid A; Drouin P; Gauthier P; Provencher D; Donath D; Van Nguyen T
    Gynecol Oncol; 2006 Jun; 101(3):445-9. PubMed ID: 16386785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage high-dose-rate brachytherapy for isolated vaginal recurrence of endometrial cancer.
    Baek S; Isohashi F; Yamaguchi H; Mabuchi S; Yoshida K; Kotsuma T; Yamazaki H; Tanaka E; Sumida I; Tamari K; Otani K; Seo Y; Suzuki O; Yoshioka Y; Kimura T; Ogawa K
    Brachytherapy; 2016; 15(6):812-816. PubMed ID: 27614661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
    Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
    Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.
    Vargo JA; Kim H; Houser CJ; Berhane H; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
    Radiother Oncol; 2014 Oct; 113(1):126-31. PubMed ID: 25241996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized study--quality-of-life analysis.
    Sorbe BG; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
    Int J Gynecol Cancer; 2012 Sep; 22(7):1281-8. PubMed ID: 22864336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
    Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
    Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatment of vaginal recurrence of endometrial carcinoma with 5-fluorouracil: case-report.
    Surico N; Ribaldone R
    Clin Exp Obstet Gynecol; 1997; 24(3):144-6. PubMed ID: 9478300
    [No Abstract]   [Full Text] [Related]  

  • 13. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy.
    Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1366-72. PubMed ID: 12873682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma.
    Horowitz NS; Peters WA; Smith MR; Drescher CW; Atwood M; Mate TP
    Obstet Gynecol; 2002 Feb; 99(2):235-40. PubMed ID: 11814503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of treatment of upper third vaginal recurrences of cervical and endometrial carcinomas with interstitial brachytherapy.
    Charra C; Roy P; Coquard R; Romestaing P; Ardiet JM; Gérard JP
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):421-6. PubMed ID: 9457831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive radiotherapy for primary vaginal cancer: correlation between treatment patterns and recurrence rate.
    Kanayama N; Isohashi F; Yoshioka Y; Baek S; Chatani M; Kotsuma T; Tanaka E; Yoshida K; Seo Y; Suzuki O; Mabuchi S; Shiki Y; Tatsumi K; Kimura T; Teshima T; Ogawa K
    J Radiat Res; 2015 Mar; 56(2):346-53. PubMed ID: 25614068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The vaginal stump recurrence rate in endometrial carcinoma in relation to the target volume of postoperative HDR-afterloading brachytherapy].
    Kloetzer KH; Günther R; Wendt T
    Strahlenther Onkol; 1997 Jan; 173(1):13-7. PubMed ID: 9082580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma.
    Jordan SE; Micaily I; Hernandez E; Ferriss JS; Miyamoto CT; Li S; Micaily B
    Brachytherapy; 2017; 16(6):1144-1151. PubMed ID: 28958736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control?
    Paydar I; DeWees T; Powell M; Mutch DG; Grigsby PW; Schwarz JK
    Brachytherapy; 2015; 14(4):427-32. PubMed ID: 25911995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial brachytherapy for salvage treatment of vaginal recurrences in previously unirradiated endometrial cancer patients.
    Nag S; Yacoub S; Copeland LJ; Fowler JM
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1153-9. PubMed ID: 12419443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.